Sentence examples for implementing clinical pathways from inspiring English sources

Hospitals try to adapt treatments to the DRG-system (reimbyrsement) by implementing clinical pathways, also oriented on the InEK calculation scheme [40], promising higher efficiency [41] and increased transparency through better documentation of the course of action.

When implementing clinical pathways, the decision makers need to consider the benefits and costs under different circumstances (e.g. market forces).

A qualitative study of the use of clinical pathways in Chinese hospitals identified lack of leadership and support for implementing clinical pathways as barriers to compliance [ 26].

However despite continuing international interest in implementing clinical pathways, the evidence base for their effectiveness in improving the quality of stroke care is still inconclusive [ 8].

The likely benefits and costs need to be considered by the local healthcare providers when implementing clinical pathways under different circumstances.

Documented barriers and enablers to implementing clinical pathways outside cancer settings [ 20- 22] highlight the lack of: resources; education and training; support from leaders; and patient reluctance to accept help or poor uptake [ 23].

59 Therefore, sample hospital managers should adopt necessary measures to reduce ALoS, for instance, implementing clinical pathway management, setting up the monitoring targets, innovating medical technology and spreading the application of ambulatory surgery, etc.

In general, systemically implemented clinical pathways have indicated a beneficial effect, with fewer hospital complications and improved documentation [ 19].

The evidence-based five step intervention within emergency departments to implement clinical pathways will be a combination of processes proposed by Doherty & Jones[ 14] and Kinsman et al.[ 7].

The sub cohort of patients having attended a personal briefing, as part of the implemented clinical pathway, significantly differed from the first patient cohort before pathway implementation (median WOMAC increase 39%, Wilcoxon p = 0.029).

To evaluate whether or not a physician's experience has an effect on costs and clinical outcomes of an implemented clinical pathway for laparoscopic-assisted vaginal hysterectomy (LAVH).